UnitedHealth Group Updates Business Outlook Ahead of Investor Conference
28 Novembro 2023 - 6:15PM
Business Wire
UnitedHealth Group (NYSE: UNH) issued financial guidance ahead
of its annual Investor Conference which takes place on November 29,
beginning at 8:00 a.m. ET.
UnitedHealth Group will introduce its 2024 outlook which
includes revenues of $400 billion to $403 billion, net earnings of
$26.20 to $26.70 per share and adjusted net earnings of $27.50 to
$28.00 per share. Adjusted net earnings only excludes the after-tax
non-cash amortization expense pertaining to acquisition-related
intangible assets. Cash flows from operations are expected to range
from $30 billion to $31 billion. As announced in the third quarter
earnings release, UnitedHealth Group 2023 net earnings are expected
to be $23.60 to $23.75 per share and adjusted net earnings $24.85
to $25.00 per share.
The Company will stream the Investor Conference presentation and
management question-and-answer portion of this meeting on its
Investor Relations page at www.unitedhealthgroup.com. Meeting
materials and a replay of the conference will be available on the
Investor Relations page.
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a health care and well-being
company with a mission to help people live healthier lives and help
make the health system work better for everyone through two
distinct and complementary businesses. Optum delivers care aided by
technology and data, empowering people, partners and providers with
the guidance and tools they need to achieve better health.
UnitedHealthcare offers a full range of health benefits, enabling
affordable coverage, simplifying the health care experience and
delivering access to high-quality care. Visit UnitedHealth Group at
www.unitedhealthgroup.com and follow UnitedHealth Group on
LinkedIn.
Non-GAAP Financial
Information
This news release presents non-GAAP financial information
provided as a complement to the results provided in accordance with
accounting principles generally accepted in the United States of
America (“GAAP”). Adjusted net earnings exclude amortization
expense of approximately $1.70 and $1.75 per share and the related
tax impacts of $0.45 and $0.45 per share for years ending December
31, 2023 and 2024, respectively, pertaining to acquisition-related
intangible assets.
Forward-Looking
Statements
The statements, estimates, projections, guidance or outlook
contained in this document include “forward-looking” statements
which are intended to take advantage of the “safe harbor”
provisions of the federal securities law. The words “believe,”
“expect,” “intend,” “estimate,” “anticipate,” “forecast,”
“outlook,” “plan,” “project,” “should” and similar expressions
identify forward-looking statements. These statements may contain
information about financial prospects, economic conditions and
trends and involve risks and uncertainties. Actual results could
differ materially from those that management expects, depending on
the outcome of certain factors including: our ability to
effectively estimate, price for and manage medical costs; new or
changes in existing health care laws or regulations, or their
enforcement or application; reductions in revenue or delays to cash
flows received under government programs; changes in Medicare, the
CMS star ratings program or the application of risk adjustment data
validation audits; the DOJ’s legal action relating to the risk
adjustment submission matter; our ability to maintain and achieve
improvement in quality scores impacting revenue; failure to
maintain effective and efficient information systems or if our
technology products do not operate as intended; cyberattacks, other
privacy/data security incidents, or our failure to comply with
related regulations; risks and uncertainties associated with our
businesses providing pharmacy care services; competitive pressures,
including our ability to maintain or increase our market share;
changes in or challenges to our public sector contract awards;
failure to achieve targeted operating cost productivity
improvements; failure to develop and maintain satisfactory
relationships with health care payers, physicians, hospitals and
other service providers; the impact of potential changes in tax
laws and regulations; increases in costs and other liabilities
associated with litigation, government investigations, audits or
reviews; failure to complete, manage or integrate strategic
transactions; risks associated with public health crises arising
from large-scale medical emergencies, pandemics, natural disasters
and other extreme events; failure to attract, develop, retain, and
manage the succession of key employees and executives; our
investment portfolio performance; impairment of our goodwill and
intangible assets; failure to protect proprietary rights to our
databases, software and related products; downgrades in our credit
ratings; and our ability to obtain sufficient funds from our
regulated subsidiaries or from external financings to fund our
obligations, maintain our debt to total capital ratio at targeted
levels, maintain our quarterly dividend payment cycle, or continue
repurchasing shares of our common stock.
This above list is not exhaustive. We discuss these matters, and
certain risks that may affect our business operations, financial
condition and results of operations, more fully in our filings with
the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By
their nature, forward-looking statements are not guarantees of
future performance or results and are subject to risks,
uncertainties and assumptions that are difficult to predict or
quantify. Actual results may vary materially from expectations
expressed or implied in this document or any of our prior
communications. You should not place undue reliance on
forward-looking statements, which speak only as of the date they
are made. We do not undertake to update or revise any
forward-looking statements, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231128699048/en/
Investors: Zack Sopcak Zack.Sopcak@uhg.com
952-936-7215
Media: Eric Hausman Eric.Hausman@uhg.com 952-936-3963
UnitedHealth (NYSE:UNH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
UnitedHealth (NYSE:UNH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024